T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.63B |
| 2 |
Merck
MRK
|
+$865M |
| 3 |
EA
Electronic Arts
EA
|
+$786M |
| 4 |
FRC
First Republic Bank
FRC
|
+$712M |
| 5 |
Intuit
INTU
|
+$692M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$21.7B |
| 2 |
Amazon
AMZN
|
+$1.26B |
| 3 |
NXP Semiconductors
NXPI
|
+$1.23B |
| 4 |
AET
Aetna Inc
AET
|
+$890M |
| 5 |
GE Aerospace
GE
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.33% |
| 2 | Financials | 16.18% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Technology | 13.88% |
| 5 | Communication Services | 9.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Elevance Health
ELV
$84.8B
| $2.16B | 0.41% |
13,085,791
-691,953
| -5% | -$110M |
|
52
Dollar General
DG
$26.6B
| $2.15B | 0.4% |
30,904,576
+4,735,236
| +18% | +$347M |
|
53
Zoetis
ZTS
$30.9B
| $2.15B | 0.4% |
40,191,607
-1,046,299
| -3% | -$56.5M |
|
|
54
NXP Semiconductors
NXPI
$59.3B
| $2.14B | 0.4% |
20,661,854
-12,185,404
| -37% | -$1.23B |
|
55
Johnson Controls International
JCI
$93.3B
| $2.12B | 0.4% |
50,295,124
+2,204,417
| +5% | +$93.2M |
|
56
Cigna
CI
$71.8B
| $2.09B | 0.39% |
14,282,947
+661,269
| +5% | +$97.4M |
|
|
AGN
57
DELISTED
Allergan plc
AGN
| $2.06B | 0.39% |
8,638,721
-660,408
| -7% | -$154M |
|
58
PepsiCo
PEP
$188B
| $2.06B | 0.39% |
18,444,357
-52,485
| -0.3% | -$5.63M |
|
59
Medtronic
MDT
$115B
| $2.02B | 0.38% |
25,131,092
+2,694,221
| +12% | +$210M |
|
60
Willis Towers Watson
WTW
$32B
| $2.02B | 0.38% |
15,434,529
-139,539
| -0.9% | -$17.7M |
|
61
Citigroup
C
$229B
| $2.01B | 0.38% |
33,603,555
-5,345,897
| -14% | -$316M |
|
62
Marriott International
MAR
$91.2B
| $2.01B | 0.38% |
21,291,702
-1,552,322
| -7% | -$135M |
|
63
Cisco
CSCO
$476B
| $1.97B | 0.37% |
58,355,643
-5,891,494
| -9% | -$191M |
|
|
HOLX
64
DELISTED
Hologic
HOLX
| $1.89B | 0.35% |
44,415,677
+1,091,863
| +3% | +$44.5M |
|
65
Tyson Foods
TSN
$19.8B
| $1.88B | 0.35% |
30,439,986
+5,465,783
| +22% | +$344M |
|
66
Qualcomm
QCOM
$170B
| $1.85B | 0.35% |
32,209,361
+7,432,443
| +30% | +$431M |
|
|
CELG
67
DELISTED
Celgene Corp
CELG
| $1.84B | 0.34% |
14,756,851
-1,589,173
| -10% | -$190M |
|
68
Verizon
VZ
$196B
| $1.81B | 0.34% |
37,067,347
-166,298
| -0.4% | -$8.34M |
|
69
Broadcom
AVGO
$1.99T
| $1.79B | 0.34% |
81,800,790
+16,660,730
| +26% | +$343M |
|
70
Fortive
FTV
$18.7B
| $1.78B | 0.33% |
46,881,420
-10,007,116
| -18% | -$359M |
|
71
Textron
TXT
$15.2B
| $1.78B | 0.33% |
37,308,940
-407,672
| -1% | -$19.7M |
|
72
NextEra Energy
NEE
$178B
| $1.75B | 0.33% |
54,659,572
+13,808,740
| +34% | +$434M |
|
|
SCHW
73
Charles Schwab
SCHW
$187B
| $1.73B | 0.33% |
42,512,892
+8,230,375
| +24% | +$340M |
|
74
Equifax
EFX
$21.4B
| $1.72B | 0.32% |
12,584,823
+5,158,452
| +69% | +$656M |
|
75
Honeywell
HON
$73.9B
| $1.7B | 0.32% |
15,069,997
+4,404,606
| +41% | +$486M |
|
Similar funds
T. Rowe Price Associates's Q1 2017 Portfolio in Review
As of Q1 2017, T. Rowe Price Associates held 2,648 positions worth $534B, up 6% from $504B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
T. Rowe Price Associates withdrew a net $29B in Q1 2017, closing 78 positions and reducing 979 holdings. Its most notable exit was Spectra Energy Corp Wi, an estimated $404M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Snap worth $632M.
- T. Rowe Price Associates's largest Q1 2017 buy was Snap: 28,319,977 shares worth $632M.
- T. Rowe Price Associates added most to Apple in Q1 2017, an estimated $2.63B increase.
- T. Rowe Price Associates's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $21.7B.
- T. Rowe Price Associates fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $404M.
- T. Rowe Price Associates's ten largest holdings make up 18% of its $534B portfolio in Q1 2017.
- T. Rowe Price Associates opened 102 new positions and closed 78 in Q1 2017.
- T. Rowe Price Associates's portfolio value rose 6% quarter-over-quarter to $534B.
Based on T. Rowe Price Associates's 13F filing for Q1 2017, filed 15 May 2017.